BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 23286786)

  • 1. Intrahippocampal injection of Aβ1-42 inhibits neurogenesis and down-regulates IFN-γ and NF-κB expression in hippocampus of adult mouse brain.
    Zheng M; Liu J; Ruan Z; Tian S; Ma Y; Zhu J; Li G
    Amyloid; 2013 Mar; 20(1):13-20. PubMed ID: 23286786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal Stem Cells Increase Hippocampal Neurogenesis and Neuronal Differentiation by Enhancing the Wnt Signaling Pathway in an Alzheimer's Disease Model.
    Oh SH; Kim HN; Park HJ; Shin JY; Lee PH
    Cell Transplant; 2015; 24(6):1097-109. PubMed ID: 24612635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early changes in hyppocampal neurogenesis induced by soluble Ab1-42 oligomers].
    Komleva YK; Lopatina OL; Gorina YV; Chernykh AI; Shuvaev AN; Salmina AB
    Biomed Khim; 2018 Aug; 64(4):326-333. PubMed ID: 30135279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice.
    Moon M; Cha MY; Mook-Jung I
    J Alzheimers Dis; 2014; 41(1):233-41. PubMed ID: 24583405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An 18-mer Peptide Derived from Prosaposin Ameliorates the Effects of Aβ1-42 Neurotoxicity on Hippocampal Neurogenesis and Memory Deficit in Mice.
    Gao HL; Li C; Nabeka H; Shimokawa T; Wang ZY; Cao YM; Matsuda S
    J Alzheimers Dis; 2016 Jun; 53(3):1173-92. PubMed ID: 27372641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Estradiol Administration During the Early Stage of Alzheimer's Disease Pathology Rescues Adult Hippocampal Neurogenesis and Ameliorates Cognitive Deficits in Aβ
    Zheng JY; Liang KS; Wang XJ; Zhou XY; Sun J; Zhou SN
    Mol Neurobiol; 2017 Dec; 54(10):7656-7669. PubMed ID: 27838872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembling nanofibers improve cognitive impairment in a transgenic mice model of Alzheimer's disease.
    Yang H; Qu T; Yang H; Wei L; Xie Z; Wang P; Bi J
    Neurosci Lett; 2013 Nov; 556():63-8. PubMed ID: 24103374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited hippocampal neurogenesis in SAMP8 mouse model of Alzheimer's disease.
    Gang B; Yue C; Han N; Xue H; Li B; Sun L; Li X; Zhao Q
    Brain Res; 2011 May; 1389():183-93. PubMed ID: 21439270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Abeta production by NF-kappaB inhibitors.
    Paris D; Patel N; Quadros A; Linan M; Bakshi P; Ait-Ghezala G; Mullan M
    Neurosci Lett; 2007 Mar; 415(1):11-6. PubMed ID: 17223266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligomers of β-amyloid protein (Aβ1-42) induce the activation of cyclooxygenase-2 in astrocytes via an interaction with interleukin-1β, tumour necrosis factor-α, and a nuclear factor κ-B mechanism in the rat brain.
    Carrero I; Gonzalo MR; Martin B; Sanz-Anquela JM; Arévalo-Serrano J; Gonzalo-Ruiz A
    Exp Neurol; 2012 Aug; 236(2):215-27. PubMed ID: 22617488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of cysteinyl leukotriene receptor 1 in Aβ1-42-induced neurotoxicity in vitro and in vivo.
    Tang SS; Hong H; Chen L; Mei ZL; Ji MJ; Xiang GQ; Li N; Ji H
    Neurobiol Aging; 2014 Mar; 35(3):590-9. PubMed ID: 24269024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble oligomers and fibrillar species of amyloid β-peptide differentially affect cognitive functions and hippocampal inflammatory response.
    He Y; Zheng MM; Ma Y; Han XJ; Ma XQ; Qu CQ; Du YF
    Biochem Biophys Res Commun; 2012 Dec; 429(3-4):125-30. PubMed ID: 23146634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrahydrohyperforin increases adult hippocampal neurogenesis in wild-type and APPswe/PS1ΔE9 mice.
    Abbott AC; Calderon Toledo C; Aranguiz FC; Inestrosa NC; Varela-Nallar L
    J Alzheimers Dis; 2013; 34(4):873-85. PubMed ID: 23302657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noggin and BMP4 co-modulate adult hippocampal neurogenesis in the APP(swe)/PS1(DeltaE9) transgenic mouse model of Alzheimer's disease.
    Tang J; Song M; Wang Y; Fan X; Xu H; Bai Y
    Biochem Biophys Res Commun; 2009 Jul; 385(3):341-5. PubMed ID: 19463786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease.
    Mirochnic S; Wolf S; Staufenbiel M; Kempermann G
    Hippocampus; 2009 Oct; 19(10):1008-18. PubMed ID: 19219917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-β induces cyclooxygenase-2 and PGE2 release in human astrocytes in NF-κ B dependent manner.
    Blanco A; Alvarez S; Fresno M; Muñoz-Fernández MÁ
    J Alzheimers Dis; 2010; 22(2):493-505. PubMed ID: 20847443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease.
    Donovan MH; Yazdani U; Norris RD; Games D; German DC; Eisch AJ
    J Comp Neurol; 2006 Mar; 495(1):70-83. PubMed ID: 16432899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 regulates neurogenesis and protects neural progenitor cells against Aβ toxicity.
    Kärkkäinen V; Pomeshchik Y; Savchenko E; Dhungana H; Kurronen A; Lehtonen S; Naumenko N; Tavi P; Levonen AL; Yamamoto M; Malm T; Magga J; Kanninen KM; Koistinaho J
    Stem Cells; 2014 Jul; 32(7):1904-16. PubMed ID: 24753106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The γ-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Aβ1-42 seeding and short-term memory deficits in the Aβ25-35 mouse model of Alzheimer's disease.
    Meunier J; Villard V; Givalois L; Maurice T
    Eur J Pharmacol; 2013 Jan; 698(1-3):193-9. PubMed ID: 23123349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.